Ticker | Name | Market cap, $ | Price, $ | Price change, %04 Nov 2024 | Type | Country | Dividend per share (last paid), $ | Dividend yield (TTM), % | PE ratio | PB ratio | PS ratio | Revenue (quarterly), $ | EPS diluted (quarterly), $ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zoetis | 79.10 B | 174.60 | -4.07 | Stock | United States | 0.43 | 0.99 | 34.17 | 15.93 | 8.87 | 2.36 B | 1.37 | |
| Takeda Pharmaceutical Company Limited | 44.54 B | 14.05 | +0.64 | Stock | Japan | 0.29 | 2.08 | 45.95 | 0.92 | 1.51 | 7.75 B | 0.19 | |
| Haleon | 44.13 B | 9.76 | -1.01 | Stock | United Kingdom | 0.05 | 1.62 | 28.85 | 3.10 | 3.62 B | 0.14 | ||
| Teva Pharmaceutical Industries Limited | 21.39 B | 18.88 | +2.39 | Stock | Israel | 0.09 | 3.36 | 1.31 | 4.16 B | -0.75 | |||
| Viatris | 13.79 B | 11.55 | -1.29 | Stock | United States | 0.12 | 4.16 | 0.71 | 0.90 | 3.80 B | -0.27 | ||
| Neurocrine Biosciences | 12.24 B | 120.87 | -1.10 | Stock | United States | 0.04 | 32.40 | 4.50 | 5.46 | 622.10 M | 1.24 | ||
| Catalent | 10.65 B | 58.69 | -0.07 | Stock | United States | 2.96 | 2.43 | 1.30 B | 0.13 | ||||
| Intra-Cellular Therapies | 9.31 B | 87.83 | +2.97 | Stock | United States | 8.13 | 15.20 | 175.16 M | -0.25 | ||||
| Lantheus Holdings | 8.12 B | 117.01 | +5.58 | Stock | United States | 19.18 | 7.91 | 5.65 | 394.09 M | 0.88 | |||
| Elanco Animal Health Incorporated | 6.15 B | 12.44 | -4.35 | Stock | United States | 1.03 | 1.37 | 1.18 B | -0.10 | ||||
| Alkermes | 4.37 B | 26.98 | +1.93 | Stock | Ireland | 13.84 | 3.38 | 2.90 | 378.14 M | 0.55 | |||
| Alvotech | 3.90 B | 12.92 | -0.77 | Stock | Luxembourg | -6.43 | 12.70 | 198.74 M | 0.28 | ||||
| Prestige Consumer Healthcare | 3.66 B | 73.79 | -0.35 | Stock | United States | 0.47 | 18.04 | 2.18 | 3.29 | 267.14 M | 0.98 | ||
| Perrigo | 3.51 B | 25.73 | +0.59 | Stock | Ireland | 0.28 | 4.28 | 0.77 | 0.79 | 1.07 B | -0.79 | ||
| Bausch Health Companies | 3.41 B | 9.27 | -4.73 | Stock | Canada | 1.00 | -2.90 | 0.36 | 2.51 B | -0.23 | |||
Ticker | Name | Market cap, $ | Price, $ | Price change, %04 Nov 2024 | Type | Country | Dividend per share (last paid), $ | Dividend yield (TTM), % | PE ratio | PB ratio | PS ratio | Revenue (quarterly), $ | EPS diluted (quarterly), $ |
On page:
On page: